Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Terzolo

Showing results (51-60 of 181) with videos related to

Pageof 19
Sort By:
Cancers|March 14, 2020
Recovery of Adrenal Insufficiency Is Frequent After Adjuvant Mitotane Therapy in Patients with Adrenocortical CarcinomaJonathan Poirier, Nadia Gagnon, Massimo Terzolo, et al.
Molecular and Cellular Endocrinology|December 16, 2014
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolizationAntonina Germano, Ida Rapa, Marco Volante, et al.
Cancers|November 13, 2021
Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro StudiesMarco Lo Iacono, Soraya Puglisi, Paola Perotti, et al.
Plos One|May 8, 2018
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cellsAntonina Germano, Laura Saba, Silvia De Francia, et al.
Molecular and Cellular Endocrinology|September 11, 2013
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell linesAntonina Germano, Ida Rapa, Marco Volante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panelAlfredo Berruti, Martin Fassnacht, Eric Baudin, et al.
International Journal of Endocrinology|June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal AdenomasGiuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Cancer Treatment Reviews|April 16, 2013
Strategies for managing ACTH dependent mineralocorticoid excess induced by abirateroneAnna Pia, Francesca Vignani, Gerhardt Attard, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 10, 2014
Intermittent everolimus administration for malignant insulinomaChiara Baratelli, Maria Pia Brizzi, Marco Tampellini, et al.
Histopathology|November 17, 2009
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratificationMarco Volante, Enrico Bollito, Paola Sperone, et al.
Pageof 19

Showing results (51-60 of 181) with videos related to

Sort By:
Pageof 19
Cancers|March 14, 2020
Recovery of Adrenal Insufficiency Is Frequent After Adjuvant Mitotane Therapy in Patients with Adrenocortical CarcinomaJonathan Poirier, Nadia Gagnon, Massimo Terzolo, et al.
Molecular and Cellular Endocrinology|December 16, 2014
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolizationAntonina Germano, Ida Rapa, Marco Volante, et al.
Cancers|November 13, 2021
Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro StudiesMarco Lo Iacono, Soraya Puglisi, Paola Perotti, et al.
Plos One|May 8, 2018
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cellsAntonina Germano, Laura Saba, Silvia De Francia, et al.
Molecular and Cellular Endocrinology|September 11, 2013
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell linesAntonina Germano, Ida Rapa, Marco Volante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panelAlfredo Berruti, Martin Fassnacht, Eric Baudin, et al.
International Journal of Endocrinology|June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal AdenomasGiuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Cancer Treatment Reviews|April 16, 2013
Strategies for managing ACTH dependent mineralocorticoid excess induced by abirateroneAnna Pia, Francesca Vignani, Gerhardt Attard, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 10, 2014
Intermittent everolimus administration for malignant insulinomaChiara Baratelli, Maria Pia Brizzi, Marco Tampellini, et al.
Histopathology|November 17, 2009
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratificationMarco Volante, Enrico Bollito, Paola Sperone, et al.
Pageof 19